A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc. that was the first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel. U.S. District Judge Matthew Kennelly …
A federal jury in Chicago on Monday found AbbVie Inc. fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages. The verdict, which came in response to a lawsuit …
Clinical testing on an experimental drug from Bial-Portela & Ca. SA, a closely held Portuguese company, led to six patients being hospitalized in France including one person who was put on life support and diagnosed as brain dead. Three of …
The U.S. Supreme Court on Monday declined to hear a Johnson & Johnson subsidiary’s appeal of a $124 million penalty imposed by South Carolina after a jury found the drugmaker had improperly marketed the anti-psychotic drug Risperdal and concealed its …
Johnson & Johnson defeated a lawsuit claiming it had improperly designed its Tylenol pain reliever in the first case to go to trial over the link between the widely used over-the-counter drug and liver damage, according to a J&J spokesman. …
Pfizer Inc.’s Zoloft antidepressant didn’t cause a boy’s birth defects, a jury concluded in the first trial of more than 1,000 lawsuits over what was once the U.S.’s most popular mood-altering drug. Jurors in state court in St. Louis Friday …
Pfizer Inc. researchers concluded last year that pregnant women taking Zoloft risked having babies with heart defects, according to evidence made public by a lawyer at the first trial of more than 1,000 lawsuits over the drug. The May 2014 …
Roche Holding AG won reversal of a $2.1 million verdict by a New Jersey jury in favor of a California woman who blamed the company’s Accutane acne drug for her inflammatory bowel disease. A judge erred in the 2011 trial …
A federal appeals court on Friday upheld the dismissal of nearly all claims in 68 cases seeking to hold drug makers liable for injuries from the use of the prescription painkillers Darvon and Darvocet, which were pulled from the U.S. …
